ChineseInvestors.com, Inc.’s (CIIX) October Presentation Available On-Demand
- Presentation from CEO Warren Wang available for on-demand viewing for 90 days
- Increase in year-over-year revenue of 70 percent and year-over-year product sales of 800 percent
- Expanded footprint through online store with targeted marketing campaign for CBD skincare line during China’s peak e-commerce season
- Announced the launch of a CBD-infused rice wine during China’s peak period of liquor sales
ChineseInvestors.com, Inc. (OTCQB: CIIX), a proprietary financial news media and content platform providing information to the global Chinese-speaking community, has made the October 2018 presentation from CEO Warren Wang available for on-demand viewing at VirtualInvestorConferences.com (http://nnw.fm/ok6Vd). Investors and advisors are encouraged to download the shareholder material from the “virtual trade booth.” The presentation will be available for 90 days.
The report highlights an increase in revenue and product sales and is credited in part to a focus on products and service in the hemp and CBD markets. CIIX is in the process of a CBD spinoff by year-end with the intention of focusing back on its original mission of providing financial information and services to the global Chinese-speaking community. Hemp and CBD products are being launched through CBD Biotechnology Co. Ltd (CBD Biotech), a wholly owned foreign enterprise of CIIX.
First quarter fiscal 2019 reports showed a year-over-year revenue increase of 70 percent and a year-over-year product sales increase of 800 percent. “With increased marketing resources devoted to our industrial hemp-based CBD products, we anticipate a productive Fiscal Year 2019. We look forward to increased product distribution both domestically and in the China markets,” Wang stated in a recent press release (http://nnw.fm/yAGT7).
CIIX expanded its footprint by opening an online store on Alibaba Group’s Tmall, China’s largest e-commerce marketplace for global and domestic brands and retailers (http://nnw.fm/1k3Sk). According to Wang, “CBD Biotechnology Co. Ltd. is not only one of the first companies to produce and sell CBD skincare products in China, but now it is the first CBD skincare company to enter Tmall.”
The company will invest a total of 2.5 million RMB ($360,875) in online marketing and advertising for the skincare line in a campaign that began on October 15 and will continue through the end of December 2018. Historically, the highest volume of sales for online merchandise in China has fallen between October and December due to two national events, Singles’ Day and Double 12 Shopping Festivals.
CIIX also recently announced the launch of a CBD hemp-infused rice wine in December, during China’s peak period for liquor sales. Wang stated that “the upcoming launch of CBD Hemp Wine will serve as a strong sales driver for the Company.” CBD Biotech has plans to explore a variety of hemp products beyond the skincare line and alcoholic beverages.
CIIX offers a variety of investor education products and services. The subscription services and new educational services covering the cryptocurrency market continue to provide a steady revenue stream. As CBD Biotech takes over the exploration and launch of new hemp and CBD products, CIIX can focus on its original mission of providing financial information and services to the global Chinese-speaking community.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Presentation from CEO Warren Wang available for on-demand viewing for 90 days
- Increase in year-over-year revenue of 70 percent and year-over-year product sales of 800 percent
- Expanded footprint through online store with targeted marketing campaign for CBD skincare line during China’s peak e-commerce season
- Announced the launch of a CBD-infused rice wine during China’s peak period of liquor sales
ChineseInvestors.com, Inc. (OTCQB: CIIX), a proprietary financial news media and content platform providing information to the global Chinese-speaking community, has made the October 2018 presentation from CEO Warren Wang available for on-demand viewing at VirtualInvestorConferences.com (http://nnw.fm/ok6Vd). Investors and advisors are encouraged to download the shareholder material from the “virtual trade booth.” The presentation will be available for 90 days.
The report highlights an increase in revenue and product sales and is credited in part to a focus on products and service in the hemp and CBD markets. CIIX is in the process of a CBD spinoff by year-end with the intention of focusing back on its original mission of providing financial information and services to the global Chinese-speaking community. Hemp and CBD products are being launched through CBD Biotechnology Co. Ltd (CBD Biotech), a wholly owned foreign enterprise of CIIX.
First quarter fiscal 2019 reports showed a year-over-year revenue increase of 70 percent and a year-over-year product sales increase of 800 percent. “With increased marketing resources devoted to our industrial hemp-based CBD products, we anticipate a productive Fiscal Year 2019. We look forward to increased product distribution both domestically and in the China markets,” Wang stated in a recent press release (http://nnw.fm/yAGT7).
CIIX expanded its footprint by opening an online store on Alibaba Group’s Tmall, China’s largest e-commerce marketplace for global and domestic brands and retailers (http://nnw.fm/1k3Sk). According to Wang, “CBD Biotechnology Co. Ltd. is not only one of the first companies to produce and sell CBD skincare products in China, but now it is the first CBD skincare company to enter Tmall.”
The company will invest a total of 2.5 million RMB ($360,875) in online marketing and advertising for the skincare line in a campaign that began on October 15 and will continue through the end of December 2018. Historically, the highest volume of sales for online merchandise in China has fallen between October and December due to two national events, Singles’ Day and Double 12 Shopping Festivals.
CIIX also recently announced the launch of a CBD hemp-infused rice wine in December, during China’s peak period for liquor sales. Wang stated that “the upcoming launch of CBD Hemp Wine will serve as a strong sales driver for the Company.” CBD Biotech has plans to explore a variety of hemp products beyond the skincare line and alcoholic beverages.
CIIX offers a variety of investor education products and services. The subscription services and new educational services covering the cryptocurrency market continue to provide a steady revenue stream. As CBD Biotech takes over the exploration and launch of new hemp and CBD products, CIIX can focus on its original mission of providing financial information and services to the global Chinese-speaking community.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
